NCT07501585

Brief Summary

This randomized clinical trial (RCT) will evaluate the effectiveness of cross-linked hyaluronic acid as an adjunct to endodontic microsurgery in adult patients with apical periodontitis affecting maxillary or mandibular first molars. Participants previously treated with non-surgical endodontic therapy will be allocated to either endodontic microsurgery with cross-linked hyaluronic acid application (test group) or the same surgical procedure without adjunctive material (control group), with 12 months of follow-up. The study hypothesis is that cross-linked hyaluronic acid improves soft- and hard-tissue healing, reduces postoperative inflammation and pain, and supports more stable surgical outcomes. Primary outcomes include early soft tissue healing (Early Wound Healing Score, day 4) and postoperative pain (visual analogue scale). Secondary outcomes include periapical healing assessed by blinded evaluators on periapical radiographs (Molven criteria) at 3, 6, and 12 months, and on CBCT scans (PENN 3D criteria) at 6 and 12 months, as well as cortical plate healing (RAC/B index). This study aims to provide clinical evidence on the potential regenerative and anti-inflammatory benefits of cross-linked hyaluronic acid in endodontic microsurgery.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for not_applicable

Timeline
32mo left

Started Feb 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Feb 2026Dec 2028

Study Start

First participant enrolled

February 20, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

March 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

1.9 years

First QC Date

March 24, 2026

Last Update Submit

March 24, 2026

Conditions

Keywords

Endodontic microsurgery

Outcome Measures

Primary Outcomes (1)

  • The healing of soft tissues will be evaluated by the Early wound healing score

    The early wound healing index assesses periodontal soft tissue healing, usually around 1 week post-surgery, by evaluating flap closure, fibrin presence, and necrosis in 5 grades. It ranges from score 1 (complete healing) to score 5 (necrosis and pus)

    4 days after surgery

Secondary Outcomes (4)

  • The postoperative pain will be evaluated by visual analogue scale VAS

    within the two first weeks after surgery

  • Periapical healing assessed on periapical radiographs according to the Molven's criteria

    3, 6, and 12 months post-surgery

  • Pericapial healing on cone beam computed tomography (CBCT) scans according to PENN's criteria

    6 and 12 months post-surgery

  • Cortical plate healing

    6 and 12 months post-surgery

Study Arms (2)

Test: endodontic microsurgery with hyaluronic acid

EXPERIMENTAL

The endodontic microsurgery will be performed, then cross-linked hyaluronic acid will be added in the surgical area.

Procedure: Hyaluronic AcidProcedure: Endodontic microsurgery

Control: mere endodontic microsurgery

ACTIVE COMPARATOR

Endodontic microsurgery will be performed only.

Procedure: Endodontic microsurgery

Interventions

The endodontic surgery will be performed under the control of an operating microscope (Carl Zeiss Extaro 300). The operation will be performed under anesthesia, articaine + epinephrine. OFD (single flap approach Trombelli 2009 combined with entire papilla preservation technique Aslan et al., flap elevation, osteotomy, 3 mm root resection, the root cut will be made at an angle close to 90 degrees, the root cut will be coloured with methylen-blue 1%, retrograde canal preparation using ultrasonic scaler, and ultrasonic tips, granulated tissues excavation, haemostasis will be achieved by using cotton balls with epinephrine, root-end filling with mineral trioxide aggregate. Irrigation with 0.9% sodium chloride, application of cross-linked hyaluronic acid through the cannula into the osteotomy, until the bone defect is completely filled and under the flap, flap reposition tension-free, suturing using monofilament sutures 7-0 (Prolene).

Test: endodontic microsurgery with hyaluronic acid

The endodontic surgery will be performed under the control of an operating microscope (Carl Zeiss Extaro 300). The operation will be performed under anesthesia, articaine + epinephrine. OFD (single flap approach Trombelli 2009 combined with entire papilla preservation technique Aslan et al., flap elevation, osteotomy, 3 mm root resection, the root cut will be made at an angle close to 90 degrees, the root cut will be coloured with methylen-blue 1%, retrograde canal preparation using ultrasonic scaler, and ultrasonic tips, granulated tissues excavation, haemostasis will be achieved by using cotton balls with epinephrine, root-end filling with mineral trioxide aggregate. Irrigation with 0.9% sodium chloride, flap reposition tension-free, suturing using monofilament sutures 7-0 (Prolene).

Control: mere endodontic microsurgeryTest: endodontic microsurgery with hyaluronic acid

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Written informed consent
  • ≥18 years of age
  • Apical peridontitis at maxillar or mandibular first molars ≥ 12 months after non-surgical endodontical treatment
  • Full mouth plaque score (FMPS) and bleeding score (BoP) \< or 20%
  • Periapical lesion \< or 10 mm
  • Four-wall bone defect morphology

You may not qualify if:

  • Smokers of more than 10 cigarettes a day
  • Allergy to hyaluronic acid
  • Pregnancy or lactation
  • Uncontrolled Diabetes
  • Untreated periodontal conditions
  • Any conditions associated with poor compliance or failure to maintain good oral hygiene
  • Acute infections lesions in areas intended for surgery
  • Chemotherapy and radiotherapy treatment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Praktika 1

Moscow, 127006, Russia

RECRUITING

MeSH Terms

Conditions

Periapical Periodontitis

Interventions

Hyaluronic Acid

Condition Hierarchy (Ancestors)

Periapical DiseasesJaw DiseasesStomatognathic DiseasesPeriodontal DiseasesMouth DiseasesPeriodontitis

Intervention Hierarchy (Ancestors)

GlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Anton Sculean, Prof.

    University of Bern

    STUDY CHAIR

Central Study Contacts

Anton Sculean, Prof.

CONTACT

Vitaly Fuog, DMD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The participants are in surgery not seeing the surgical intervention and not knowing if adjunctive HA will be applied. The outcome assessor is not involved in the patient allocation nor the surgical intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: This is a double-armed, single-center, double-blinded randomized controlled clinical trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

February 20, 2026

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations